Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.23
-0.53 (-9.20%)
At close: Apr 28, 2026, 4:00 PM EDT
5.32
+0.09 (1.72%)
After-hours: Apr 28, 2026, 6:28 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $339.01 million as of April 28, 2026. Its market cap has increased by 661.82% in one year.
Market Cap
339.01M
Enterprise Value
125.82M
1-Year Change
661.82%
Ranking
Category
Stock Price
$5.23
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $339.01M, a decrease of -7.33%. That is a compound annual growth rate of -1.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 372.66M | -12.29% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 382.55M |
| YD Bio | 372.34M |
| Rocket Pharmaceuticals | 372.11M |
| X4 Pharmaceuticals | 370.04M |
| vTv Therapeutics | 368.44M |
| Silence Therapeutics | 366.06M |
| Monopar Therapeutics | 362.04M |
| Opus Genetics | 357.73M |